Pharmaceutical Technology - Pharmaceutical Manufacturing & Development News & Research for Scientists

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Featured Articles
Antibody-Drug Conjugates: Looking Ahead to an Emerging Class of Biotherapeutic
Creating a successful antibody-drug conjugate requires careful selection of the drug, antibody, and linker.
Multilayer-Tablet Technology
Industry experts discuss formulation and technical challenges in multilayer tablet manufacture.
Assessing Tablet-Sticking Propensity
The authors designed an upper punch with a removable punch tip to determine a tablet formulation's propensity to stick by weighing the mass of powder adhered to the punch tip.
Report from Europe
The European Union market takes steps toward continuous processing and modular facilities.
The Employment Outlook Brightens
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
See who's showing at 2011 industry exhibitions
pharmtech corporate capabilities 2012
Fast Locator2011

Personalizing for Better Products
Public Safety versus Public Disclosure
Bring Manufacturing Back, Orders Obama
Celebrity Chef and Pharma Unite
Generic Drug and Biosimilar User Fees Gain Traction
TwitterLinkedIn
Industry Leaders: Q+A
Q&A with Gilles Cottier, SAFC
A Q&A with Gilles Cottier, president of SAFC, on recent industry trends.
Survey
What is the most important change that has influenced chemical API manufacturing during the past 10 years?
advancements in chemocatalysis (for use in asymmetric hydrogenation and other asymmetric syntheses)
adoption of biocatalysis in organic chemical synthesis
development of microreactors for continuous manufacturing
application of quality-by-design principles in process development and manufacturing
advancements in chemocatalysis (for use in asymmetric hydrogenation and other asymmetric syntheses)
13%
adoption of biocatalysis in organic chemical synthesis
11%
development of microreactors for continuous manufacturing
17%
application of quality-by-design principles in process development and manufacturing
58%
View Results
Events
January 30, 2012 - February 1, 2012
Cool Chain Logistics Europe 2012
January 30, 2012 - January 31, 2012
Novel Immunotherapeutics Summit
February 2, 2012 - February 3, 2012
Computer System Validation - Reduce Costs and Avoid 483s
Regulatory Corner
Standards & Regulations
FDA Perspectives: Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time
The author describes how providing appropriate information about the API in the Common Technical Document can aid FDA's review of an abbreviated new drug application.
Inside USP: Global Harmonization Presents Opportunities and Challenges
To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.
Budget Crunch, Political Battles Shape Policy Agenda for Year
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
Regulatory Roundup: USP Releases Proposed Supply Chain Guidelines
USP Releases Guidelines on Ensuring the Integrity of the Pharmaceutical Supply Chain.
Jim MillerOutsourcing OutlookJim Miller Contract Services in 2012
Patricia Van ArnumIngredients InsiderPatricia Van ArnumBroadening the Toolbox in Drug Development and Analysis
Nathan JessopIndustry InsiderNathan Jessop European Pharma Companies Set To Surge Ahead Of US Rivals
Lynn D. TorbeckStatistical Solutions Lynn D. TorbeckOut-of-Specification Sample-Size Confusion
FindPharma Custom Search
Click here